Investor FAQs

Show all

The company’s headquarters are located at 480 Arsenal Way, Watertown, MA 02472. The main office number is 617-923-1400.
Selecta is traded on the NASDAQ Global Market under the ticker symbol SELB, and its CUSIP number is 816212 104
Selecta’s initial public offering (IPO) occurred on June 22, 2016.
Selecta’s underwriters were UBS Investment Bank, Stifel, Canaccord Genuity and Needham & Company.
Selecta does not currently offer a dividend reinvestment program, and does not expect to declare or pay dividends on our common stock in the foreseeable future.
If you have misplaced your stock certificates, please contact Selecta’s transfer agent, American Stock Transfer & Trust Company, LLC. There may be a fee involved for replacing lost stock certificates.
Shares can be purchased through a stockbroker of your choice. Selecta does not have a direct stock purchase plan.
The company’s fiscal year ends on December 31st.
Communication regarding transfer requirements, lost certificates, and change of address should be directed to:

American Stock Transfer & Trust Company
6201 15th Avenue
Brooklyn, NY 11219
800-937-5449
Legal Counsel: Latham & Watkins LLP
Name: Peter N. Handrinos
Address: John Hancock Tower, 27th Floor, 200 Clarendon Street
City, State, Zip Code: Boston, MA 02116
Phone Number 617-948-6000

Ernst & Young LLP
200 Clarendon Street
Boston, MA 02116
617-266-2000
Quarterly and annual reports, as well as other SEC filings, can be accessed in the Financial Information section of our Investors & Media webpage or directly from the SEC at www.sec.gov.
You can submit questions to Selecta’s head of investor relations, Jason Fredette, at jfredette@selectabio.com